Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab | |
Ding, Jinhua; Yang, Yinlong; Jiang, Li; Wu, Weizhu; Shao, Zhiming | |
刊名 | ONCOTARGET |
2017 | |
卷号 | 8期号:34 |
关键词 | breast cancer neoadjuvant chemotherapy human epidermal growth factor receptor 2 (HER2) Ki67 pathological complete response (pCR) |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3618251 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Ding, Jinhua,Yang, Yinlong,Jiang, Li,et al. Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab[J]. ONCOTARGET,2017,8(34). |
APA | Ding, Jinhua,Yang, Yinlong,Jiang, Li,Wu, Weizhu,&Shao, Zhiming.(2017).Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab.ONCOTARGET,8(34). |
MLA | Ding, Jinhua,et al."Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab".ONCOTARGET 8.34(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论